Evidence map›Paper›PMID 22952446›Full record

ArticlePLoS pathogens2012

Measles immune suppression: lessons from the macaque model.

Rory D de Vries, Stephen McQuaid, Geert van Amerongen, Selma Yüksel, R Joyce Verburgh, Albert D M E Osterhaus, W Paul Duprex, Rik L de Swart

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06923631 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Unravelling the Measles Paradox in Children: a Disease Associated With Both Immune Suppression and Immune Activation

TypeobservationalSponsorErasmus Medical CenterRan2026 to 2029Enrolled100ConditionsMEASLES DISEASE
NCT07267585 recruitingnot on this mapstarted 2025, after this paper: background citation

Unravelling the Measles Paradox: a Disease Associated With Both Immune Suppression and Immune Activation

TypeobservationalSponsorErasmus Medical CenterRan2025 to 2028Enrolled300ConditionsMEASLES DISEASE
3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 189 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Measles virus reprograms CD4Frontiers in cell and developmental biology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Rory D de VriesViroscience Lab, Erasmus MC, Rotterdam, The Netherlands.
Stephen McQuaid
Geert van Amerongen
Selma Yüksel
R Joyce Verburgh
Albert D M E Osterhaus
W Paul Duprex
Rik L de Swart
Erasmus University Rotterdam · NLErasmus MC · NLBelfast Health and Social Care Trust · GBBoston University · US

Funding

Medical Research Council G0801001
6 · The paper itself

Abstract

Measles remains a significant childhood disease, and is associated with a transient immune suppression. Paradoxically, measles virus (MV) infection also induces robust MV-specific immune responses. Current hypotheses for the mechanism underlying measles immune suppression focus on functional impairment of lymphocytes or antigen-presenting cells, caused by infection with or exposure to MV. We have generated stable recombinant MVs that express enhanced green fluorescent protein, and remain virulent in non-human primates. By performing a comprehensive study of virological, immunological, hematological and histopathological observations made in animals euthanized at different time points after MV infection, we developed a model explaining measles immune suppression which fits with the "measles paradox". Here we show that MV preferentially infects CD45RA(-) memory T-lymphocytes and follicular B-lymphocytes, resulting in high infection levels in these populations. After the peak of viremia MV-infected lymphocytes were cleared within days, followed by immune activation and lymph node enlargement. During this period tuberculin-specific T-lymphocyte responses disappeared, whilst strong MV-specific T-lymphocyte responses emerged. Histopathological analysis of lymphoid tissues showed lymphocyte depletion in the B- and T-cell areas in the absence of apoptotic cells, paralleled by infiltration of T-lymphocytes into B-cell follicles and reappearance of proliferating cells. Our findings indicate an immune-mediated clearance of MV-infected CD45RA(-) memory T-lymphocytes and follicular B-lymphocytes, which causes temporary immunological amnesia. The rapid oligoclonal expansion of MV-specific lymphocytes and bystander cells masks this depletion, explaining the short duration of measles lymphopenia yet long duration of immune suppression.

Indexed as

Immunosuppression TherapyAnimalsAntigen-Presenting CellsB-LymphocytesDisease Models, AnimalFemaleFluorescent DyesGreen Fluorescent ProteinsHumansImmunologic MemoryLeukocyte Common AntigensLeukopeniaLymphocyte DepletionLymphoid TissueMacacaMaleenhanced green fluorescent proteinFluorescent DyesGreen Fluorescent ProteinsLeukocyte Common Antigens

Identifiers

PMID22952446
PMCPMC3431343
OpenAlexW2096950785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.